FR2427822A1 - MEDICINE FOR THE TREATMENT OF CIRCULATORY DISEASES, BASED ON 5-METHYL-7-DIMETHYLAMINO-S-TRIAZOLO (1,5-A) PYRIMIDINE - Google Patents

MEDICINE FOR THE TREATMENT OF CIRCULATORY DISEASES, BASED ON 5-METHYL-7-DIMETHYLAMINO-S-TRIAZOLO (1,5-A) PYRIMIDINE

Info

Publication number
FR2427822A1
FR2427822A1 FR7914149A FR7914149A FR2427822A1 FR 2427822 A1 FR2427822 A1 FR 2427822A1 FR 7914149 A FR7914149 A FR 7914149A FR 7914149 A FR7914149 A FR 7914149A FR 2427822 A1 FR2427822 A1 FR 2427822A1
Authority
FR
France
Prior art keywords
triazolo
pyrimidine
methyl
treatment
dimethylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7914149A
Other languages
French (fr)
Other versions
FR2427822B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Publication of FR2427822A1 publication Critical patent/FR2427822A1/en
Application granted granted Critical
Publication of FR2427822B1 publication Critical patent/FR2427822B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

Médicament pour le traitement des maladies circulatoires chez les mammifères contenant à titre de principe actif, la 5-méthyl-7-diéthylamino-S-triazolo (1,5-a)-pyrimidine, ce médicament étant actif contre l'artériosclérose, l'hypertension et l'hypercholestérolémie.Medicinal product for the treatment of circulatory diseases in mammals containing, as active ingredient, 5-methyl-7-diethylamino-S-triazolo (1,5-a) -pyrimidine, this medicinal product being active against arteriosclerosis, hypertension and high cholesterol.

FR7914149A 1978-06-06 1979-06-01 MEDICINE FOR THE TREATMENT OF CIRCULATORY DISEASES, BASED ON 5-METHYL-7-DIMETHYLAMINO-S-TRIAZOLO (1,5-A) PYRIMIDINE Granted FR2427822A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6790178A JPS54160745A (en) 1978-06-06 1978-06-06 Circulatory disease treating agent

Publications (2)

Publication Number Publication Date
FR2427822A1 true FR2427822A1 (en) 1980-01-04
FR2427822B1 FR2427822B1 (en) 1983-08-26

Family

ID=13358252

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7914149A Granted FR2427822A1 (en) 1978-06-06 1979-06-01 MEDICINE FOR THE TREATMENT OF CIRCULATORY DISEASES, BASED ON 5-METHYL-7-DIMETHYLAMINO-S-TRIAZOLO (1,5-A) PYRIMIDINE

Country Status (4)

Country Link
JP (1) JPS54160745A (en)
DE (1) DE2922478A1 (en)
FR (1) FR2427822A1 (en)
GB (1) GB2026861B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5681517A (en) * 1979-12-07 1981-07-03 Mochida Pharmaceut Co Ltd Drug having inhibiting action of thromboxane a2
JPS56104818A (en) * 1980-01-24 1981-08-20 Mochida Pharmaceut Co Ltd Pharmaceutical composition having cerebral and peripheral blood flow improving activity
JPS60193990A (en) * 1984-03-12 1985-10-02 Yoshitomi Pharmaceut Ind Ltd Novel polyaza heterocyclic derivative

Also Published As

Publication number Publication date
FR2427822B1 (en) 1983-08-26
GB2026861A (en) 1980-02-13
GB2026861B (en) 1983-04-27
DE2922478A1 (en) 1979-12-13
JPS54160745A (en) 1979-12-19

Similar Documents

Publication Publication Date Title
DE3582439D1 (en) MEDICINE FOR TREATING HEART DISEASES.
DE3382641T2 (en) MEDICINE FOR THERAPEUTIC TREATMENT OF ALOPEZIA.
TR199801180T2 (en) New compounds with analgesic effect.
FR2512670B1 (en) CAPSULES CONTAINING THE ACTIVE INGREDIENT OF AN ALLERGEN AND PROCESS FOR THEIR PREPARATION
ATE204178T1 (en) METHOD FOR TREATING AND PREVENTING TYPE 1 DIABETIS BY ORAL ADMINISTRATION OF INSULIN
NO166448C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TIAZOLIDE INDIANS.
MA23744A1 (en) PROCESS FOR THE PREPARATION OF SULFONAMIDES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE
DE3776946D1 (en) NASAL ADMINISTRATION OF MEDICINAL PRODUCTS.
ATE67677T1 (en) MEDICATIONS FOR ORAL ADMINISTRATION CONTAINING 10 TO 240 MG OF DIHYDROPYRIDINE IN A SINGLE DOSE.
FR2558373B1 (en) ANTI-ESTROGEN MEDICINAL PRODUCT BASED ON 4-HYDROXYTAMOXIFENE FOR PERCUTANEOUS ADMINISTRATION
IS1565B (en) Process for the preparation of N1-substituted benzimidazole derivatives for therapeutic use
MC1915A1 (en) Processes for the preparation of 2 ', 3'-dideoxynucleosides and pharmaceutical formulations containing them
MC2078A1 (en) USE OF ALEZASTINE AS AN ACTIVE INGREDIENT AGAINST PSORIASIS AND INFLAMMATORY DISEASES
ATE182271T1 (en) MEDICINAL PRODUCTS FOR THE TREATMENT OF CANCER, AIDS AND VIRUS DISEASES
IT8721115A0 (en) PHYTO-PREPARATION FOR THE TREATMENT OF SKIN DISEASES.
HUP9901303A2 (en) A pharmaceutical composition for the treatment of autoimmune diseases
TR199801184T2 (en) New compounds with analgesic action.
FR2427822A1 (en) MEDICINE FOR THE TREATMENT OF CIRCULATORY DISEASES, BASED ON 5-METHYL-7-DIMETHYLAMINO-S-TRIAZOLO (1,5-A) PYRIMIDINE
NL187299C (en) FORMED PHARMACEUTICAL DOSAGE UNIT FOR THE TREATMENT OF HEART AND Vascular Diseases.
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
EP0305277A3 (en) Use of 2-amino-6-trifluoromethoxybenzothiazole for the preparation of a medicament for the treatment of sleep disorders and depression
KR880004810A (en) Peptic Ulcer Treatment
DE68905076T2 (en) Pharmaceutical composition for the treatment of skin wounds.
NO862321D0 (en) PHYSIOLOGICAL AGENT FOR INCREASING TRANSDERMAL DELIVERY OF MEDICINAL PRODUCTS.
ATE130192T1 (en) USE OF 15-DEOXYSPERGUALIN AS A MEDICINAL PRODUCT.

Legal Events

Date Code Title Description
ST Notification of lapse